| Profitability | 37/100 |
| Growth | 60/100 |
| Momentum | 88/100 |
| Quality | 67/100 |
| Earnings Quality | 82/100 |
| Balance Sheet | 45/100 |
| Value | 48/100 |
| Risk (safety) | 15/100 |
| Overall | 41.2/100 |
| Symbol | IS Score |
|---|---|
| OHI | 69 |
| AHR | 62 |
| CTRE | 81 |
| HR | 32 |
| SBRA | 39 |
| VTR | 53 |
| DOC | 41 |
Both readings sit below the midpoint — business quality at 41 and price structure at 28 out of 100 — so they are not in conflict. The fundamentals and the tape are saying the same thing, which is the case in which either one alone would have been enough.
| Trigger | Where it stands now | What it would mean |
|---|---|---|
| IS Score reaches 55 and holds two consecutive quarters | now 41.2 | would move us up one band |
| IS Score stops falling - one quarter higher than the prior | last four: 32 → 37 → 39 → 41 | the direction matters more than the level |
| Technical vote share back above 50% | now 18% | price structure no longer broken |
| Institutional holder count rises two quarters running | peak 767 → now 762 | fewer institutions willing to hold is our clearest warning |
This page is InsiderStreet's own reading, produced from the data in the rest of this document. It is not a price target and not investment advice. Analyst consensus and street price targets appear later under their own heading and are the street's numbers, not ours.
| Quarter | Holders | 13F shares | Value | Reported own% |
|---|---|---|---|---|
| 2026 Q2 | 762 | 672.4M | $14.3B | 97.5% |
| 2026 Q1 | 756 | 683.5M | $11.1B | 99.1% |
| 2025 Q4 | 767 | 664.8M | $10.6B | 96.4% |
| 2025 Q3 | 746 | 651.2M | $12.4B | 94.4% |
| 2025 Q2 | 729 | 652.6M | $11.4B | 94.6% |
| 2025 Q1 | 754 | 664.0M | $13.3B | 96.2% |
| 2024 Q4 | 758 | 650.0M | $13.2B | 94.2% |
| 2024 Q3 | 731 | 643.8M | $14.6B | 93.3% |
| 2024 Q2 | 702 | 640.8M | $12.5B | 92.9% |
| 2024 Q1 | 675 | 643.2M | $12.2B | 93.2% |
| 2023 Q4 | 612 | 511.7M | $10.4B | 74.2% |
| 2023 Q3 | 584 | 512.7M | $9.4B | 74.3% |
| Insider | Role | Date | Type | Shares | Value | Post-Txn Owned |
|---|---|---|---|---|---|---|
| Thomas John T | director | 2026-05-29 | A-Award | 1,385 | $0.02M | 830,053 |
| Thomas John T | director | 2026-05-29 | TAX W/H | 78 | $0.00M | 829,975 |
| Patadia Ankit B. | EVP and Treasurer | 2026-05-29 | A-Award | 1,358 | $0.02M | 9,047 |
| Patadia Ankit B. | EVP and Treasurer | 2026-05-29 | TAX W/H | 94 | $0.00M | 8,953 |
| Moses Kelvin O | Chief Financial Officer | 2026-05-29 | A-Award | 937 | $0.01M | 1,692 |
| Moses Kelvin O | Chief Financial Officer | 2026-05-29 | TAX W/H | 65 | $0.00M | 1,627 |
| Mabry Adam G | CIO | 2026-05-29 | A-Award | 625 | $0.01M | 5,140 |
| Mabry Adam G | CIO | 2026-05-29 | TAX W/H | 43 | $0.00M | 5,097 |
| 6-mo decomposition (Form 4) | Txns | Shares | Value | Signal weight |
|---|---|---|---|---|
| S — Open-market sales | 1 | 10,989 | $0.2M | Counted |
| F — Tax withholding | 6 | 470 | $0.0M | None — compensation |
| G — Gifts | 1 | 60,186 | — | None |
| P — Open-market purchases | 0 | 0 | $0 | Counted — none occurred |
| Filed | Filer | Shares registered | Est. proceeds |
|---|---|---|---|
| 2026-05-12 | Bohn Scott R | 10,989 | $0.2M |
| 2025-07-01 | Scott Peter A | 100,050 | $1.8M |
| 2024-04-29 | Garvey Christine | 9,200 | $0.2M |
| Trailing 12 mo | 1 filings | 10,989 | $0M |
| Filed | Form | Reporting person | % of class | Shares |
|---|---|---|---|---|
| 2026-08-07 | SCHEDULE 13G | STATE STREET CORPORATION | 6.40% | 44.0M sh |
| 2026-07-22 | SCHEDULE 13G/A | JPMORGAN CHASE & CO. | 4.30% | 29.9M sh |
| 2026-05-13 | SCHEDULE 13G | JPMORGAN CHASE & CO | 6.10% | 43.1M sh |
| 2026-04-30 | SCHEDULE 13G | Vanguard Capital Management | 7.42% | 51.6M sh |
| Member | Chamber | Trade | Size band | Traded | Disclosed |
|---|---|---|---|---|---|
| Gilbert Cisneros | House | BUY | $1,001 - $15,000 | 2026-01-09 | 2026-02-13 |
| Gilbert Ray Cisneros | House | BUY | $1,001 - $15,000 | 2026-01-08 | 2026-02-13 |
| Lisa C. McClain | House | SELL | $1,001 - $15,000 | 2025-08-03 | 2025-09-15 |
| Manager | Shares | Value |
|---|---|---|
| Douglas Lane & Associates, Llc | 2.4M | $48M |
| Davenport & Co Llc | 543,039 | $11M |
| Northside Capital Management, Llc | 395,297 | $8M |
| Wealth Enhancement Advisory Servic | 257,978 | $4M |
| 1834 Investment Advisors Co | 206,239 | $4M |
| Czech National Bank | 198,118 | $4M |
| Fund | Weight | Position |
|---|---|---|
| VGSLX | 0.8% | $521M |
| VGSNX | 0.8% | $521M |
| VNQ | 0.8% | $521M |
| VITSX | 0.0% | $438M |
| VTI | 0.0% | $438M |
| VTSAX | 0.0% | $438M |
| ATS Venue (4-wk) | Shares | Avg trade |
|---|---|---|
| Ebxl Level Ats | 7.0M | 69 sh |
| Incr Intelligent Cross Llc | 6.7M | 128 sh |
| Mstx Ms Trajectory Cross (Ats-1) | 5.9M | 154 sh |
| Ubsa Ubs Ats | 4.4M | 99 sh |
| Bids Bids Ats | 3.1M | 836 sh |
| Pure Purestream | 2.9M | 51 sh |
| Region | Revenue | Share |
|---|---|---|
| Outpatient Medical Buildings | $1.3B | 47% |
| Lab | $860M | 31% |
| Senior Housing | $604M | 22% |
Moat score 44/100 — Weak; primary source Efficient Scale.
| Officer | Title |
|---|---|
| Scott Brinker | President, Chief Executive Officer & Director |
| Adam G. Mabry | Chief Investment Officer |
| Kelvin O. Moses | Chief Financial Officer |
| Scott R. Bohn | Chief Development Officer & Head of Lab |
| Period | EPS est. | EPS actual | EPS surprise | Rev est. ($M) | Rev actual ($M) | Rev surprise |
|---|
| YoY growth | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | +15.3% | +8.7% | +5.8% | +23.8% | +4.5% |
| Gross profit | +30.2% | +6.7% | +6.7% | +27.1% | -61.0% |
| Operating income | +58.2% | +4.8% | +21.7% | +8.6% | +15.5% |
| Net income | +22.2% | -1.0% | -38.9% | -20.5% | -70.7% |
| $B · FY ends | FY21 | FY22 | FY23 | FY24 | FY25 | Trend |
|---|---|---|---|---|---|---|
| Revenue | 1.9 | 2.1 | 2.2 | 2.7 | 2.8 | |
| Cost of revenue | 0.8 | 0.9 | 0.9 | 1.1 | 2.2 | |
| Gross profit | 1.1 | 1.2 | 1.3 | 1.6 | 0.6 | |
| R&D expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| SG&A expense | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Operating income | 0.3 | 0.4 | 0.4 | 0.5 | 0.5 | |
| EBITDA | 1.0 | 1.4 | 1.3 | 1.6 | 1.6 | |
| D&A | 0.7 | 0.7 | 0.7 | 1.1 | 1.1 | |
| Pretax income | 0.1 | 0.5 | 0.3 | 0.3 | 0.1 | |
| Income tax | -0.0 | -0.0 | -0.0 | 0.0 | 0.0 | |
| Net income | 0.5 | 0.5 | 0.3 | 0.2 | 0.1 | |
| Diluted EPS ($) | 0.93 | 0.92 | 0.56 | 0.36 | 0.10 | |
| Diluted shares (M) | 539 | 539 | 547 | 676 | 696 |
| $B | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|
| Cash & equivalents | 0.1 | 0.1 | 0.1 | 0.5 | |
| ST investments | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables (net) | 0.4 | 0.3 | 0.8 | 0.7 | |
| Total current assets | 0.6 | 0.6 | 1.0 | 1.1 | |
| PP&E (net) | 0.2 | 0.2 | 0.4 | 0.4 | |
| Goodwill + intangibles | 0.4 | 0.3 | 0.8 | 0.7 | |
| Total assets | 15.8 | 15.7 | 19.9 | 20.3 | |
| Accounts payable | 0.3 | 0.2 | 0.3 | 0.7 | |
| Short-term debt | 1.0 | 0.7 | 0.2 | 0.0 | |
| Deferred revenue | 0.0 | 0.0 | 0.0 | 1.0 | |
| Total current liabilities | 1.8 | 1.4 | 0.9 | 1.0 | |
| Long-term debt | 5.5 | 6.2 | 8.6 | 10.1 | |
| Total liabilities | 8.5 | 8.8 | 10.9 | 12.0 | |
| Shareholders' equity | 7.3 | 6.9 | 9.1 | 8.3 |
| $B | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|
| Net income | 0.5 | 0.3 | 0.3 | 0.1 | |
| D&A | 0.7 | 0.7 | 1.1 | 1.1 | |
| Stock-based compensation | 0.0 | 0.0 | 0.0 | 0.0 | |
| Working capital change | 0.1 | 0.1 | 0.0 | 0.1 | |
| Operating cash flow | 0.9 | 1.0 | 1.1 | 1.3 | |
| Capital expenditures | 0.0 | 0.0 | 0.0 | (0.1) | |
| Investing cash flow | (0.9) | (0.6) | (0.1) | (1.1) | |
| Buybacks | (0.1) | (0.0) | (0.2) | (0.1) | |
| Dividends paid | (0.6) | (0.7) | (0.8) | (0.8) | |
| Debt issuance / (repay) | 0.3 | 0.4 | 0.2 | 1.1 | |
| Financing cash flow | (0.1) | (0.3) | (0.9) | 0.1 | |
| Free cash flow | 0.9 | 1.0 | 1.1 | 1.1 |
| Ratio | FY21 | FY22 | FY23 | FY24 | FY25 | TTM | Trend |
|---|---|---|---|---|---|---|---|
| PROFITABILITY | |||||||
| ROE | 7.6% | 7.6% | 4.7% | 3.3% | 0.9% | 3% | |
| ROA | 3.2% | 3.2% | 1.9% | 1.4% | 0.4% | 1.2% | |
| ROIC | 2.7% | 2.7% | 3.4% | 2.7% | 2.9% | 16.1% | |
| Gross margin | 59.2% | 58.1% | 58.6% | 60.2% | 22.5% | 2.5% | |
| Operating margin | 17.9% | 17.3% | 19.9% | 17.4% | 19.3% | 17.6% | |
| Net margin | 26.7% | 24.3% | 14.0% | 9.0% | 2.5% | 8.6% | |
| EBITDA margin | 51.2% | 67.5% | 58.0% | 59.6% | 56.8% | 59.2% | |
| FCF margin | 41.9% | 43.7% | 43.8% | 39.6% | 43.4% | — | |
| VALUATION | |||||||
| P/E | 30.21 | 22.41 | 31.16 | 54.53 | 156.87 | 54.2 | |
| P/B | 2.34 | 1.69 | 1.50 | 1.58 | 1.49 | 1.7 | |
| P/S | 8.05 | 5.44 | 4.37 | 4.91 | 3.97 | 4.44 | |
| P/FCF | 19.21 | 12.46 | 9.97 | 12.38 | 9.14 | 44.2 | |
| EV/EBITDA | 22.14 | 12.83 | 13.04 | 13.76 | 13.16 | 12.5 | |
| EV/Revenue | 11.33 | 8.66 | 7.57 | 8.21 | 7.47 | 7.4 | |
| Earnings yield | 3.3% | 4.5% | 3.2% | 1.8% | 0.6% | 1.94% | |
| FCF yield | 5.2% | 8.0% | 10.0% | 8.1% | 10.9% | 2.26% | |
| Ratio | FY21 | FY22 | FY23 | FY24 | FY25 | TTM | Trend |
|---|---|---|---|---|---|---|---|
| LEVERAGE & SOLVENCY | |||||||
| Current ratio | 0.37 | 0.34 | 0.41 | 1.13 | 1.09 | 2.52 | |
| Quick ratio | 0.37 | 0.34 | 0.41 | 1.13 | 1.09 | 2.52 | |
| Debt / equity | 0.98 | 1.01 | 1.12 | 1.07 | 1.39 | 1.32 | |
| Debt / assets | 41.8% | 42.5% | 45.1% | 45.3% | 51.3% | 47.6% | |
| Net debt / EBITDA | 6.40 | 4.77 | 5.51 | 5.53 | 6.18 | 4.98 | |
| Interest coverage | 1.81 | 3.93 | 2.57 | 1.97 | 1.78 | — | |
| Ratio | FY21 | FY22 | FY23 | FY24 | FY25 | TTM | Trend |
|---|---|---|---|---|---|---|---|
| EFFICIENCY | |||||||
| Asset turnover | 0.12 | 0.13 | 0.14 | 0.15 | 0.14 | 0.14 | |
| Receivables turnover | 41.69 | 40.36 | 39.92 | 40.72 | 7.42 | 11.3 | |
| DSO (days) | 9 | 9 | 9 | 9 | 49 | 32 | |
| DPO (days) | 117 | 104 | 102 | 88 | 83 | 32 | |
| Cash conversion cycle | -108 | -95 | -93 | -79 | -34 | 1 | |
| GROWTH (YoY) | |||||||
| Revenue growth | 74.5% | 8.7% | 5.8% | 23.8% | 4.5% | — | |
| Net income growth | 22.2% | -1.0% | -38.9% | -20.5% | -70.7% | — | |
| EPS growth | 22.0% | -0.8% | -39.9% | -37.8% | -70.5% | — | |
| FCF growth | 4.9% | 13.2% | 6.2% | 11.9% | 14.4% | — | |
| PER SHARE ($) | |||||||
| EPS (diluted, TTM) | 0.94 | 0.93 | 0.56 | 0.35 | 0.10 | 0.37 | |
| Book value / share | 12.08 | 12.36 | 11.60 | 12.01 | 10.78 | 13.77 | |
| Revenue / share | 3.51 | 3.83 | 3.98 | 3.86 | 4.06 | 4.28 | |
| FCF / share | 1.47 | 1.67 | 1.75 | 1.53 | 1.76 | 0.43 | |
| Cash / share | 0.29 | 0.13 | 0.21 | 0.17 | 0.77 | 2.36 | |
| SHAREHOLDER RETURN & SCORES | |||||||
| Buyback yield | 0.1% | 0.6% | 0.1% | 1.4% | 0.9% | 0.69% | |
| Altman Z-Score | 0.84 | 0.60 | 0.84 | 0.60 | 0.38 | 0.9 | |
| Piotroski F-Score | 5 | 5 | 6 | 6 | 5 | 7/9 | |
| Beneish M-Score | — | -2.82 | -2.89 | -1.17 | -3.76 | -3.19 | |
| Model | Score | Zone | Note |
|---|---|---|---|
| Piotroski F-Score | 7 / 9 | Strong | |
| Altman Z-Score | 0.9 | Distress (<1.81) | Distress |
| Income quality | 4.48 | Cash-backed | OCF ÷ net income |
| Beneish M-Score | -3.19 | Non-manipulator | vs −2.22 threshold |
| DuPont Decomposition (TTM) | Value |
|---|---|
| Tax burden | 0.91 |
| Interest burden | 0.41 |
| Operating margin | 23.2% |
| Asset turnover | 0.14× |
| Financial leverage | 2.63× |
| = ROE | 3% |
| Growth Quality (live) | Value |
|---|---|
| Revenue stability | 0.98 |
| Earnings stability | 0.34 |
| Earnings persistence | 0.50 |
| Revenue CAGR 3y | 11.7% |
| EPS CAGR 3y | -27.6% |
| FCF CAGR 3y | -31.5% |
| Company | Mkt cap | P/E | ROE | Net margin | Rev growth | Piotroski | 1-yr ret |
|---|---|---|---|---|---|---|---|
| OHI | $13.8B | 15.8 | 17% | — | +15.9% | 6/9 | +14.9% |
| AHR | $11.6B | 78.2 | 4% | 4.5% | +16.4% | 6/9 | +25.4% |
| CTRE | $8.6B | 22.7 | 9% | 55.2% | +96.2% | 6/9 | +8.2% |
| HR | $6.1B | -66.6 | -2% | -15.4% | -4.8% | 6/9 | -3.4% |
| SBRA | $4.9B | 73.3 | 2% | -10.7% | +17.3% | 5/9 | — |
| VTR | $44.0B | 156.1 | 2% | 4.3% | +21.5% | 6/9 | — |
| NHI | $3.3B | 19.1 | 11% | 45.9% | +24.4% | 5/9 | — |
| MPW | $3.2B | 974.5 | 0% | 6.9% | -13.6% | 5/9 | — |
| Consensus estimates | Revenue mean | High / Low | EPS mean | High / Low | # EPS est. |
|---|---|---|---|---|---|
| FY2026 | $3.01B | $3.05B / $2.98B | $0.46 | $0.46 / $0.45 | 2 |
| FY2027 | $3.21B | $3.28B / $3.12B | $0.22 | $0.23 / $0.21 | 4 |
| FY2028 | $3.48B | $3.63B / $3.24B | $0.29 | $0.31 / $0.27 | 2 |
| Window | Avg Target | vs. Price | # Targets |
|---|---|---|---|
| Last Month | $20.50 | +8.0% | 2 |
| Last Quarter | $21.80 | +14.9% | 5 |
| Last Year | $20.45 | +7.7% | 20 |
| All Time | $20.44 | +7.7% | 41 |
| Moving Average | Value | Distance | % Distance | Signal |
|---|---|---|---|---|
| SMA 20 | $19.50 | -0.52 | -2.67% | Below |
| SMA 50 | $20.25 | -1.27 | -6.27% | Below |
| SMA 200 | $18.97 | +0.01 | +0.05% | Above |
| EMA 9 | $19.00 | -0.02 | -0.11% | Below |
| EMA 21 | $19.40 | -0.42 | -2.16% | Below |
| EMA 50 | $20.00 | -1.02 | -5.10% | Below |
| EMA 200 | $19.42 | -0.44 | -2.27% | Below |
| Level | Value | Level | Value |
|---|---|---|---|
| Pivot / R1 / R2 | $18.95 / $19.12 / $19.28 | S1 / S2 | $18.79 / $18.62 |
| Bollinger (20,2) | $18.05 – $20.94 | Squeeze | Off |
| 52-wk range | $15.67 – $22.95 | Off 52-wk high | -17.3% |
| ATR (14) | $0.40 (2.1%) | Historical vol | 21.1% |
| Computed from live weekly prices | DOC | S&P 500 |
|---|---|---|
| Weekly volatility (σ, 1y) | 4.20% | 1.83% |
| Best / worst week (1y) | +19.0% / -6.8% | — |
| Max drawdown (5y, monthly) | -48.9% | — |
| 1-week VaR (95%) | -5.3% | — |
| Beta (5y) | 0.99 | 1.00 |
| Reading | DOC | REIT - Healthcare Facilities n=43 | Real Estate n=2,764 | All US symbols n=70,435 |
|---|---|---|---|---|
| Overall | -43.9 | -23.5 | -28.0 | -20.5 |
| Trend | -36.3 | -43.1 | -37.3 | -21.3 |
| Momentum | -30.8 | +2.2 | -17.0 | -15.8 |
| Volume | -56.8 | -25.0 | -26.6 | -3.8 |
| Executive | Total comp | Structure |
|---|---|---|
| Scott M. Brinker President and Chief Executi | $10.1M | 91% equity+incentive |
| Kelvin O. Moses Chief Financial Officer | $3.6M | 85% equity+incentive |
| Thomas M. Klaritch Former Chief Operating Of | $2.9M | 43% equity+incentive |
| Adam G. Mabry Chief Investment Officer | $2.9M | 80% equity+incentive |
| Scott R. Bohn Chief Development Officer and | $2.6M | 78% equity+incentive |
| Pillar (live disclosure scores) | Score |
|---|---|
| Environmental | 78 |
| Social | 66 |
| Governance | 72 |
| Composite ESG | 72 |
| Filed | 8-K contents | Items |
|---|---|---|
| 2026-08-04 | Earnings Release; Regulation FD; Exhibits | 2.02,7.01,9.01 |
| 2026-05-05 | Earnings Release; Regulation FD; Exhibits | 2.02,7.01,9.01 |
| 2026-05-04 | Shareholder Vote | 5.07 |
| 2026-03-23 | Material Agreement; Financial Obligation; Exhibits | 1.01,2.03,9.01 |
| 2026-02-27 | Regulation FD Disclosure | 7.01 |
| 2026-02-02 | Results of Operations and Financial Condition; Regulation FD Disclosur | 2.02,7.01,9.01 |
| 2025-10-23 | Results of Operations and Financial Condition; Regulation FD Disclosur | 2.02,7.01,9.01 |
| 2025-08-14 | Other Events; Financial Statements and Exhibits | 8.01,9.01 |
Methodology. Every figure originates in InsiderStreet's production data layer and is computed deterministically by the same engines that power insiderstreet.ai. This factsheet contains no model-written text. Sections without underlying data are omitted rather than estimated.
| Data domain | Source | Coverage for this report |
|---|---|---|
| Price & volume | market_db.historical_prices | 52 rows |
| Fundamentals | income_statements_annual | 6 rows · 2020 to 2025 |
| Reported vs consensus | fact/earnings_calendar | 24 rows · 2020-11-02 to 2026-08-04 |
| Analyst estimates | dim/forward_estimates | 3 rows · 2026-12-31 to 2028-12-31 |
| Institutional ownership (13F) | holdings_db.institutional_ownership_summary | 51 rows · 2010 to 2026 |
| Insider transactions (Form 4) | edgar/form4 | 12 rows · 2026-05-29 |
| Proposed sales (Form 144) | edgar/form144 | 1 record |
| Beneficial ownership (13D/G) | edgar/13dg | 4 rows · 2026-04-30 to 2026-08-07 |
| Short-sale volume (FINRA) | edgar/short_volume_daily | 60 rows · 2026-07-23 to 2026-10-15 |
| Dark pool (ATS, tier 1) | edgar/darkpool_weekly | 12 rows · 2026-06-15 to 2026-08-31 |
| ETF & fund holding | etf_holdings_changelog (30d) | 1 record |
| Peer set | stock_peers_dynamic | 8 rows |
| Industry medians | industry_medians | 1 record |
| Congressional trades | congress_db (House + Senate) | 1 record |
| ESG | fact/esg_disclosures | 1 record |
Method. Every figure in this factsheet is looked up from a named field computed in code. It contains no model-written text.
Not covered. Short interest as a percent of float and days-to-cover are not in this data set — the short-sale figures above are FINRA volume, a flow, and cannot support squeeze or covering analysis. Options positioning and intraday data are also absent. 13F ownership is filed 45 days after quarter end and congressional trades are disclosed on a lag, so both describe a past position, not a current one.